ainvest

Gazyva Just Won a New Approval. It's a Real Medical Win and a Nearly Weightless Reason to Own Roche

- FDA approved Genentech's Gazyva as first steroid-sparing treatment for pediatric nephrotic syndrome, addressing a rare ...